Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1445328rdf:typepubmed:Citationlld:pubmed
pubmed-article:1445328lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:1445328lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:1445328lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:1445328lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:1445328lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:1445328lifeskim:mentionsumls-concept:C0075191lld:lifeskim
pubmed-article:1445328pubmed:issue2lld:pubmed
pubmed-article:1445328pubmed:dateCreated1992-12-4lld:pubmed
pubmed-article:1445328pubmed:abstractTextStarting from highly potent HIV-1 protease pepstatine analog inhibitors, we have tried to find the minimum consensus sequence which is necessary to conserve anti-protease potency and antiviral activity. We describe here some statine based tripeptides which exhibit high affinity for the protease and are able to inhibit the reproductive cycle of HIV-1 in MT-4-infected cells.lld:pubmed
pubmed-article:1445328pubmed:languageenglld:pubmed
pubmed-article:1445328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:citationSubsetIMlld:pubmed
pubmed-article:1445328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1445328pubmed:statusMEDLINElld:pubmed
pubmed-article:1445328pubmed:monthOctlld:pubmed
pubmed-article:1445328pubmed:issn0006-291Xlld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:ChermannJ CJClld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:FehrentzJ AJAlld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:NisatoDDlld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:BignonEElld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:ChomierBBlld:pubmed
pubmed-article:1445328pubmed:authorpubmed-author:VenaudSSlld:pubmed
pubmed-article:1445328pubmed:issnTypePrintlld:pubmed
pubmed-article:1445328pubmed:day30lld:pubmed
pubmed-article:1445328pubmed:volume188lld:pubmed
pubmed-article:1445328pubmed:ownerNLMlld:pubmed
pubmed-article:1445328pubmed:authorsCompleteYlld:pubmed
pubmed-article:1445328pubmed:pagination873-8lld:pubmed
pubmed-article:1445328pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:meshHeadingpubmed-meshheading:1445328-...lld:pubmed
pubmed-article:1445328pubmed:year1992lld:pubmed
pubmed-article:1445328pubmed:articleTitleStatine based tripeptides as potent inhibitors of HIV-1 replication.lld:pubmed
pubmed-article:1445328pubmed:affiliationSanofi Recherche, Montpellier, France.lld:pubmed
pubmed-article:1445328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1445328pubmed:publicationTypeComparative Studylld:pubmed